Direct Thrombin Inhibitors in Acute Coronary Syndromes

This publication has 44 references indexed in Scilit:

• Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin
  Journal of Biological Chemistry, 2001
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial
  Published by Oxford University Press (OUP) ,2000
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis
  The Lancet, 2000
• Challenges in the conduct and interpretation of Phase II (pilot) randomized trials
  American Heart Journal, 2000
• Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina
  European Heart Journal, 1999
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial
  The Lancet, 1999
• Heparin Is More Effective Than Inogatran, a Low-Molecular Weight Thrombin Inhibitor in Suppressing Ischemia and Recurrent Angina in Unstable Coronary Disease 11This study was supported by a grant from Astra-Hässle AB, Mölndal; and the Swedish Heart and Lung Foundation, Stockholm, Sweden.
  The American Journal of Cardiology, 1998
• Low-Molecular-Weight Heparins
  New England Journal of Medicine, 1997
• Kinetic Mechanism for the Interaction of Hirulog with Thrombin
  Biochemistry, 1994
• The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
  New England Journal of Medicine, 1992